http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Backblaze, Inc. Investors to Inquire About Securities Class Action Investigation - BLZE
-
ROSEN, A LEADING LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action - RBGLY
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DDD
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
ROSEN, A HIGHLY REGARDED INVESTOR RIGHTS FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR
-
Resverlogix Announces Voting Results from the 2025 Meeting of Shareholders
-
Dollar General Announces Call for Small Businesses
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT
-
Powers Health forges Prime Vendor agreement with Medline
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Canadian Gold Corp. Closes Over-Subscribed Private Placement for New Hammond Reef South Program
-
ELV DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action
-
Halozyme Therapeutics (HALO) added to Russell 1000
-
Halozyme Therapeutics Added to Russell 1000® Index
-
ROSEN, A LONGSTANDING FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
AHF Urges Vaccine Equity as Mpox Cases Surge in Sierra Leone
-
Cymbiotika Celebrates 2025 Great Place To Work Certification™
-
DeFi Technologies (DEFI) announces voting results from AGM
-
Greenberg Traurig's Barbara Meili Named to Sports Business Journal's 'Game Changers: Women in Sports Business' 2025 Class
-
DeFi Technologies Announces 2025 AGM Results
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - VSTS
-
Claranova: PlanetArt Division Sale to GA Credit and Management Completed
-
Greenberg Traurig Lawyers Recognized on Forbes' Inaugural America's Best-In-State Lawyers List
-
ERIC CHURCH TO LIVESTREAM TRILOGY OF COMPLETELY UNIQUE RED ROCKS SHOWS EXCLUSIVELY ON NUGS, A PREMIUM PAY-PER-VIEW EXPERIENCE
-
SOVRN NAMES JUD VALESKI CHIEF TECHNOLOGY OFFICER
-
Neo Pepe Announces Full Decentralization of Treasury via Community Governance DAO
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
LPRO DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Open Lending Corporation Investors to Secure Counsel Before Important June 30 Deadline in Securities Class Action - LPRO
-
CICADA Finance Successfully Completes Token Generation Event (TGE) on BNB Chain on the 29th
-
PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer
-
Autotrader Names Best Car Interiors Under $50,000 for 2025
-
Rubrik Is Named a Leader in the 2025 Gartner® Magic Quadrant™ for Backup and Data Protection Platforms
-
Mineralys Therapeutics (MLYS) announces positive results from Phase 3 Launch-HTN trial
-
Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat
-
Golden Corral Selects Flybuy to Power "Golden Corral Favorites" Off-Premise Experience
-
Introducing the BR30 Smart Color Bulb: Our Best Lighting Solution for Recessed Fixtures Yet
-
Arcturus Therapeutics (ARCT) Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase Deficiency Program
-
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
-
42 Fast Buds Evolves: New Logo, Same Rebel Spirit
-
Mercantile Bank Corporation Announces Second Quarter 2025 Results Conference Call and Webcast
-
Nimanode Presale Skyrockets with over 38% Allocation Scooped, Is this the Next DeFi Mover for Altseason?
-
Excellence Recognised: ADROSONIC Shines at Industry Awards
-
Former Wall Street Trader Kenna Miles Launches Legacy Trading Academy to Help a New Generation Master the Markets
-
June's Top 10 Celebrity Real Estate News: Paris Hilton, Billy Joel, Beyoncé & Jay-Z
-
SchoolDay Launches SchoolDay Academy to Advance AI Skills in K-12
-
UKG Named Official HR, Payroll, and Workforce Management Technology Partner of the LPGA
-
Byline Bank Included in U.S. News & World Report’s 2025-2026 Best Companies to Work For


